Phase I study to evaluate the safety and efficacy of MEDI4736 in combination with tremelimumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) Meeting Abstract


Authors: Siu, L. L.; Papadopoulos, K. P.; Tsai, F. Y. C.; Hansen, A. R.; Robbins, P. B.; Li, X.; Lai, D. W.; Blake-Haskins, J. A.; Fury, M. G.
Abstract Title: Phase I study to evaluate the safety and efficacy of MEDI4736 in combination with tremelimumab in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN)
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036904706
PROVIDER: wos
DOI: 10.1200/JCO.2015.33.15_suppl.tps3090
Notes: Meeting Abstract: TPS3090 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew G Fury
    102 Fury